Delivery Order SPE2DX16D4016-SPE2DX24FFECB
Award Date 1/29/24
Potential Completion Date 1/29/24
Potential Value $2.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $2,334.80 by the Defense Logistics Agency (DLA) Troop Support Medical to supply pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for $1,592.14. The contract is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. This award is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $2,206.39 by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, which has a completion date of March 6, 2024, is for the provision of pharmaceutical products and medical supplies to support U.S. military treatment programs and facilities. This award is part of a larger indefinite delivery contract (IDC) with a potential...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $2,638.48 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up...
- Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, has been awarded a $12,345.34 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of pharmaceutical and medical supplies to support military treatment programs and facilities. This contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $45,711.30 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract valued at $10,464.71 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a performance period through January 31, 2024 and is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. This award is issued under a larger indefinite delivery contract (IDC) with a potential...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $15,301.80 by the Defense Logistics Agency (DLA) Troop Support Medical. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,913.40 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order contract falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $9,630.36 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide a range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This order is issued under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
- SPE2DX16D4016Indefinite Delivery Contract
- SPE2DX16D4016-SPE2DX24FFECBDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $2,265.29 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The contract does not have a set-aside designation.
Generated 4/29/24, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 1/29/24 |